Advertisement

Surgery Today

, Volume 37, Issue 3, pp 270–271 | Cite as

HER2 Expression in Gastrointestinal Carcinoid Tumors: High in Intestinal but not in Gastric Tumors

  • Masahiko Yamaguchi
  • Kiyotaka Hirose
  • Nobuyuki Hirai
Short Communications

Abstract

We investigated HER2 expression immunohistochemically in 12 patients with a gastrointestinal (GI) carcinoid tumor. The tumors were located in the stomach in three patients, the duodenum in four, the vermiform appendix in one, and the rectum in four. HER2 was highly expressed in the nine intestinal, but not in the three gastric carcinoid tumors. These findings suggest that HER2 might be highly expressed in intestinal, but not in gastric, carcinoid tumors.

Key words

HER2 Carcinoid tumor Gastrointestinal tract 

References

  1. 1.
    Modlin, IM, Kidd, M, Latich, I, Zikusoka, MN, Shapiro, MD 2005Current status of gastrointestinal carcinoidsGastroenterology128171751PubMedCrossRefGoogle Scholar
  2. 2.
    Slamon, DJ, Clark, GM, Wong, SG, Levine, WJ, Ullrich, A, McGuire, WL 1987Human breast cancer: correlation of relapse and survival with amplification of the HER2/neu oncogeneScience23517782PubMedCrossRefGoogle Scholar
  3. 3.
    Wang, D-G, Johnston, CF, Buchanan, KD 1997Oncogene expression in gastroenteropancreatic neuroendocrine tumorsCancer8066875PubMedCrossRefGoogle Scholar
  4. 4.
    Evers, BM, Rady, PL, Tyring, SK, Sanchez, RL, Rajaraman, S, Townsend, CM,Jr,  et al. 1992Amplification of the HER-2/neu protooncogene in human endocrine tumorsSurgery1122118PubMedGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 2007

Authors and Affiliations

  • Masahiko Yamaguchi
    • 1
  • Kiyotaka Hirose
    • 1
  • Nobuyuki Hirai
    • 1
  1. 1.Department of SurgeryDokkyo Medical University Koshigaya HospitalKoshigayaJapan

Personalised recommendations